Authors' Reply to Gandjour "The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review"
Appl Health Econ Health Policy
.
2016 Dec;14(6):731-732.
doi: 10.1007/s40258-016-0284-8.
Authors
Suzanne Laplante
1
,
Frank X Liu
1
,
Bruce Culleton
1
,
Angelito Bernardo
1
,
Denise King
2
,
Pollyanna Hudson
3
Affiliations
1
Baxter Healthcare Corporation, Deerfield, IL, 60015, USA.
2
Abacus International, Bicester, UK.
[email protected]
.
3
Abacus International, Bicester, UK.
PMID:
27744597
DOI:
10.1007/s40258-016-0284-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Cost-Benefit Analysis*
Humans
Renal Dialysis*